Aroa Biosurgery Limited
ASX:ARX.AX
0.5 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 34.568 | 17.246 | 29.467 | 14.685 | 31.275 | 15.868 | 26.492 | 20.601 | 16.805 | 12.3 | 8.566 | 11.363 | 12.458 |
| Cost of Revenue
| 4.686 | 2.332 | 4.683 | 2.333 | 5.014 | 2.41 | 4.513 | 4.714 | 4.3 | 3.694 | 3.098 | 3.311 | 3.02 |
| Gross Profit
| 29.882 | 14.914 | 24.784 | 12.353 | 26.26 | 13.457 | 21.978 | 15.887 | 12.505 | 8.606 | 5.468 | 8.052 | 9.439 |
| Gross Profit Ratio
| 0.864 | 0.865 | 0.841 | 0.841 | 0.84 | 0.848 | 0.83 | 0.771 | 0.744 | 0.7 | 0.638 | 0.709 | 0.758 |
| Reseach & Development Expenses
| 3.77 | 1.881 | 4.717 | 2.351 | 3.982 | 2.153 | 5.163 | 4.47 | 3.234 | 3.136 | 2.443 | 2.269 | 2.214 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 31.39 | 15.661 | 26.233 | 13.074 | 24.945 | 12.656 | 18.577 | 15.776 | 13.124 | 10.832 | 7.989 | 9.194 | 6.654 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 35.161 | 17.155 | 30.95 | 15.533 | 28.927 | 14.709 | 23.739 | 20.246 | 16.358 | 13.968 | 10.431 | 11.464 | 8.868 |
| Operating Income
| -5.279 | -2.306 | -6.166 | -2.625 | -2.667 | -0.895 | -1.761 | -4.359 | -3.853 | -5.362 | -4.963 | -3.412 | 0.571 |
| Operating Income Ratio
| -0.153 | -0.134 | -0.209 | -0.179 | -0.085 | -0.056 | -0.066 | -0.212 | -0.229 | -0.436 | -0.579 | -0.3 | 0.046 |
| Total Other Income Expenses Net
| 1.318 | 0.33 | 0.466 | -0.216 | 0.762 | -0.072 | 3.285 | 1.307 | -0.879 | 0.063 | -7.57 | -1.771 | -1.259 |
| Income Before Tax
| -3.961 | -1.976 | -5.7 | -2.841 | -1.905 | -0.966 | 1.524 | -3.052 | -4.732 | -5.3 | -12.533 | -5.183 | -0.688 |
| Income Before Tax Ratio
| -0.115 | -0.115 | -0.193 | -0.193 | -0.061 | -0.061 | 0.058 | -0.148 | -0.282 | -0.431 | -1.463 | -0.456 | -0.055 |
| Income Tax Expense
| 0.056 | 0.028 | 0.13 | 0.065 | -0.082 | 0.042 | 0.091 | 0.059 | 0.058 | 0.042 | 0.058 | -0.335 | 0.141 |
| Net Income
| -4.017 | -2.004 | -5.83 | -2.906 | -1.823 | -0.925 | 1.433 | -3.112 | -4.791 | -5.342 | -12.591 | -4.848 | -0.829 |
| Net Income Ratio
| -0.116 | -0.116 | -0.198 | -0.198 | -0.058 | -0.058 | 0.054 | -0.151 | -0.285 | -0.434 | -1.47 | -0.427 | -0.067 |
| EPS
| -0.012 | -0.006 | -0.017 | -0.009 | -0.005 | -0.003 | 0.004 | -0.009 | -0.015 | -0.018 | -0.042 | -0.016 | -0.003 |
| EPS Diluted
| -0.012 | -0.006 | -0.017 | -0.009 | -0.005 | -0.003 | 0.004 | -0.009 | -0.015 | -0.018 | -0.042 | -0.016 | -0.003 |
| EBITDA
| -3.171 | -1.516 | -4.186 | -1.857 | -0.83 | -0.163 | -0.092 | -2.863 | -2.396 | -3.543 | -3.903 | -1.817 | 1.584 |
| EBITDA Ratio
| -0.092 | -0.088 | -0.142 | -0.126 | -0.027 | -0.01 | -0.003 | -0.139 | -0.143 | -0.288 | -0.456 | -0.16 | 0.127 |